| Autumn Lake Healthcare At Long Green | |
| 115 East Melrose Avenue, Baltimore, Maryland 21212 | |
| (410) 435-9073 | |
| Name | Autumn Lake Healthcare At Long Green |
|---|---|
| Location | 115 East Melrose Avenue, Baltimore, Maryland |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 135 |
| Occupancy Rate | 82.59% |
| Medicare ID (CCN) | 215031 |
| Legal Business Name | Legal Business Name Not Available |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1487836953 |
| Organization Name | 115 EAST MELROSE AVENUE OPERATIONS LLC |
| Doing Business As | LONG GREEN CENTER |
| Address | 115 E Melrose Ave, Baltimore, MD 21212 |
| Phone Number | 410-435-9073 |
News Archive
TransMolecular, Inc., a developer of innovative oncology drugs through targeted delivery technologies, today announced final results from its Phase 2 clinical study comparing the toxicity and overall survival of three versus six intracavitary injections of its anti-cancer compound 131I-TM601 in the treatment of recurrent malignant glioma.
Research from Queen Mary University of London reveals positive aspects of working life - such as high levels of control at work, good support from supervisors and colleagues, and feeling cared for - support higher levels of wellbeing among Britain's workers.
People who live in areas of higher than average deprivation are more likely to be admitted to hospital and to spend longer in hospital, according to new research from the University of Cambridge.
Experts believe that tuberculosis, or TB, has been a scourge for humans for some 15,000 years, with the first medical documentation of the disease coming out of India around 1000 B.C.E.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
› Verified 5 days ago
| NPI Number | 1871535153 |
| Organization Name | MERIDIAN HEALTH, INC |
| Doing Business As | LONG GREEN CENTER |
| Address | 115 E Melrose Ave, Baltimore, MD 21212 |
| Phone Number | 410-435-9073 |
News Archive
TransMolecular, Inc., a developer of innovative oncology drugs through targeted delivery technologies, today announced final results from its Phase 2 clinical study comparing the toxicity and overall survival of three versus six intracavitary injections of its anti-cancer compound 131I-TM601 in the treatment of recurrent malignant glioma.
Research from Queen Mary University of London reveals positive aspects of working life - such as high levels of control at work, good support from supervisors and colleagues, and feeling cared for - support higher levels of wellbeing among Britain's workers.
People who live in areas of higher than average deprivation are more likely to be admitted to hospital and to spend longer in hospital, according to new research from the University of Cambridge.
Experts believe that tuberculosis, or TB, has been a scourge for humans for some 15,000 years, with the first medical documentation of the disease coming out of India around 1000 B.C.E.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
TransMolecular, Inc., a developer of innovative oncology drugs through targeted delivery technologies, today announced final results from its Phase 2 clinical study comparing the toxicity and overall survival of three versus six intracavitary injections of its anti-cancer compound 131I-TM601 in the treatment of recurrent malignant glioma.
Research from Queen Mary University of London reveals positive aspects of working life - such as high levels of control at work, good support from supervisors and colleagues, and feeling cared for - support higher levels of wellbeing among Britain's workers.
People who live in areas of higher than average deprivation are more likely to be admitted to hospital and to spend longer in hospital, according to new research from the University of Cambridge.
Experts believe that tuberculosis, or TB, has been a scourge for humans for some 15,000 years, with the first medical documentation of the disease coming out of India around 1000 B.C.E.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 28.84 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.05 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 42.86 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.15 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.5 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.4 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.25 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 84.71 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 17.33 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 81.9 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 3.6 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 41.45 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 10.85 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9.75 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 91.73 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 73.76 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 84.26 | 82.93 |
News Archive
TransMolecular, Inc., a developer of innovative oncology drugs through targeted delivery technologies, today announced final results from its Phase 2 clinical study comparing the toxicity and overall survival of three versus six intracavitary injections of its anti-cancer compound 131I-TM601 in the treatment of recurrent malignant glioma.
Research from Queen Mary University of London reveals positive aspects of working life - such as high levels of control at work, good support from supervisors and colleagues, and feeling cared for - support higher levels of wellbeing among Britain's workers.
People who live in areas of higher than average deprivation are more likely to be admitted to hospital and to spend longer in hospital, according to new research from the University of Cambridge.
Experts believe that tuberculosis, or TB, has been a scourge for humans for some 15,000 years, with the first medical documentation of the disease coming out of India around 1000 B.C.E.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
› Verified 5 days ago
King David Nursing And Rehabilitation Center Location: 4204 Old Milford Mill Road, Baltimore, Maryland 21208 Phone: (410) 486-1500 | |
Autumn Lake Healthcare At Long Green Location: 115 East Melrose Avenue, Baltimore, Maryland 21212 Phone: (410) 435-9073 | |
Levindale Hebrew Ger Ctr & Hsp Location: 2434 W. Belvedere Avenue, Baltimore, Maryland 21215 Phone: (410) 466-8700 | |
Keswick Multi-care Center Location: 700 West 40th Street, Baltimore, Maryland 21211 Phone: (410) 235-8860 | |
St. Elizabeth Rehab. & Nsg. Ce Location: 3320 Benson Avenue, Baltimore, Maryland 21227 Phone: (667) 600-2600 | |
Autumn Lake Healthcare At Homewood Location: 6000 Bellona Avenue, Baltimore, Maryland 21212 Phone: (410) 323-4223 |